1. Home
  2. PAHC vs PGRE Comparison

PAHC vs PGRE Comparison

Compare PAHC & PGRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • PGRE
  • Stock Information
  • Founded
  • PAHC 1946
  • PGRE 1978
  • Country
  • PAHC United States
  • PGRE United States
  • Employees
  • PAHC N/A
  • PGRE N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • PGRE Real Estate Investment Trusts
  • Sector
  • PAHC Health Care
  • PGRE Real Estate
  • Exchange
  • PAHC Nasdaq
  • PGRE Nasdaq
  • Market Cap
  • PAHC 1.5B
  • PGRE 1.4B
  • IPO Year
  • PAHC 2014
  • PGRE 2014
  • Fundamental
  • Price
  • PAHC $38.81
  • PGRE $6.54
  • Analyst Decision
  • PAHC Hold
  • PGRE Hold
  • Analyst Count
  • PAHC 4
  • PGRE 5
  • Target Price
  • PAHC $27.50
  • PGRE $6.15
  • AVG Volume (30 Days)
  • PAHC 256.6K
  • PGRE 7.2M
  • Earning Date
  • PAHC 11-05-2025
  • PGRE 10-29-2025
  • Dividend Yield
  • PAHC 1.27%
  • PGRE N/A
  • EPS Growth
  • PAHC 1895.04
  • PGRE N/A
  • EPS
  • PAHC 1.19
  • PGRE N/A
  • Revenue
  • PAHC $1,296,215,000.00
  • PGRE $701,980,000.00
  • Revenue This Year
  • PAHC $14.80
  • PGRE $1.41
  • Revenue Next Year
  • PAHC $3.16
  • PGRE N/A
  • P/E Ratio
  • PAHC $31.66
  • PGRE N/A
  • Revenue Growth
  • PAHC 27.37
  • PGRE 35.23
  • 52 Week Low
  • PAHC $16.16
  • PGRE $3.75
  • 52 Week High
  • PAHC $41.57
  • PGRE $7.85
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 57.53
  • PGRE 40.37
  • Support Level
  • PAHC $35.81
  • PGRE $6.51
  • Resistance Level
  • PAHC $41.36
  • PGRE $6.56
  • Average True Range (ATR)
  • PAHC 1.31
  • PGRE 0.02
  • MACD
  • PAHC -0.40
  • PGRE 0.01
  • Stochastic Oscillator
  • PAHC 50.45
  • PGRE 30.00

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About PGRE Paramount Group Inc.

Paramount Group Inc is a real estate investment trust engaged in owning, operating, managing, acquiring, and redeveloping high-quality, Class A office properties in select central business district (CBD) submarkets of New York City and San Francisco. The company operates in two geographical segments New York and San Francisco. The company derives nearly all of its majority of revenue from rental income.

Share on Social Networks: